Author

M. Volk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Pharmacology & Toxicology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

F. Uckun· 2 shared K. Sahin· 2 shared A. Geber· 1 shared A. K. Heroven· 1 shared A. M. Davidson· 1 shared A.-S. Herbrüggen· 1 shared B. Zhou· 1 shared c. orhan· 1 shared

Activity by Year

2016-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

F. Uckun

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

RNase-mediated reprogramming of Yersinia virulence

I. Meyer, M. Volk, I. Salto, T. Moesser, A.-S. Herbrüggen, M. Rohde, M. Beckstette, A. K. Heroven, P. Dersch

This study identifies RNase III and PNPase as key regulators of virulence gene expression in Yersinia pseudotuberculosis by modulating lcrF mRNA stability and translation.

bioRxiv · Jan 11, 2024 · PreprintMicrobiology

Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix

F. Uckun, c. orhan, J. Powell, E. Sahin, I. Ozercan, M. Volk, K. Sahin

This study shows two Rejuveinix formulations have a favorable safety profile in rats and similarly increase antioxidant levels in tissues, indicating bioequivalence.

bioRxiv · Jan 3, 2021Pharmacology & Toxicology

Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders

F. Uckun, M. Tuzcu, M. Gitterle, M. Volk, K. Sahin

Rejuveinix improves survival in sepsis model mice by reducing brain oxidative stress, suggesting potential for neuroprotective use in sepsis and COVID-19.

bioRxiv · Jan 3, 2021 · PreprintPharmacology & Toxicology

Microbial composition of the human nasopharynx varies according to influenza virus type and vaccination status.

T. Ding, T. Song, B. Zhou, A. Geber, Y. Ma, L. Zhang, M. Volk, S. N. Kapadia, S. G. Jenkins, M. Salvatore, E. Ghedin

The paper examines how influenza virus type and vaccination status influence nasopharyngeal microbiota composition in infected individuals and healthy controls.

bioRxiv · May 24, 2019Microbiology

Experimental and Computational Investigation of the Structure of Peptide Monolayers on Gold Nanoparticles

E. Colangelo, Q. Chen, A. M. Davidson, D. Paramelle, M. B. Sullivan, M. Volk, R. Levy

The paper develops a computational model of peptide-capped gold nanoparticles, validated by experiments, revealing new structural features of monolayers.

bioRxiv · Oct 25, 2016Biochemistry